Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 10 2021 - 7:13AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2021.
Commission File Number: 001-40627
SOPHiA GENETICS SA
(Exact name of registrant as specified in its
charter)
Rue du Centre
172
CH-1025 Saint-Sulpice
Switzerland
(Address of principal
executive office)
Indicate by check
mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
SOPHiA GENETICS SA
|
Date: November 10, 2021
|
|
|
|
|
By:
|
/s/ Daan van Well
|
|
Name:
|
Daan van Well
|
|
Title:
|
Chief Legal Officer
|
EXHIBIT INDEX
Exhibit No.
|
Description
|
99.1
|
Unaudited interim condensed consolidated financial statements as of and for the three and nine
months ended September 30, 2021
|
99.2
|
Management’s discussion and analysis of financial condition and results of operations
|
99.3
|
Press Release dated November 10, 2021
|
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2024 to Jun 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2023 to Jun 2024